Screener
ImmunityBio, Inc. IBRX Intangibles (Net)
Intangibles (Net) at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.
The source filing: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 7:37 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001326110-26-000059
| Line item | March 31, 2026 / Weighted- Average Life Remaining(in years) | March 31, 2026 / Gross Carrying Amount | March 31, 2026 / Accumulated Amortization | Net Carrying Amount |
|---|---|---|---|---|
| Definite-lived: | ||||
| Favorable leasehold rights | 2.8 | $20,398 | $(8,946) | $11,452 |
| Developed technology | 4.3 | 542 | (81) | 461 |
| Total definite-lived assets | 20,940 | (9,027) | 11,913 | |
| Indefinite-lived: | ||||
| Goodwill | 910 | — | 910 | |
| In-process software development | 62 | — | 62 | |
| Total indefinite-lived assets | 972 | — | 972 |
ITEM 1. FINANCIAL STATEMENTS.
FAQ
- What is ImmunityBio, Inc.'s intangibles (net)?
- ImmunityBio, Inc. (IBRX) reported intangibles (net) of $11.91M in Q1 2026.
- How has ImmunityBio, Inc.'s intangibles (net) changed year-over-year?
- ImmunityBio, Inc.'s intangibles (net) decreased by 15.0% year-over-year, from $14.02M to $11.91M.
- What is the long-term trend for ImmunityBio, Inc.'s intangibles (net)?
- Over 4 years (2020 to 2025), ImmunityBio, Inc.'s intangibles (net) has grown at a 72.6% compound annual growth rate (CAGR), from $1.46M to $12.99M.
- What does intangibles (net) mean?
- Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.
Ask your AI about ImmunityBio, Inc.'s intangibles (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude